Article Details
Retrieved on: 2024-06-23 12:43:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
Cambrian Biopharma leverages biotechnology and induced pluripotent stem cell (iPSC) technology to target aging and age-related diseases. The company integrates a focus on hallmarks of aging, stem cells, and senescence in its therapeutic pipeline development.
Article found on: www.lifespan.io
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here